Cargando…
Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for Clostridioides difficile
BACKGROUND: Inflammatory bowel disease (IBD) and Clostridioides difficile infection (CDI) can present with similar symptoms. The current preferred method for diagnosing CDI is the nucleic acid amplification test (NAAT) for C. difficile in stool, followed by reflex toxin enzyme immunoassay (EIA) when...
Autores principales: | Johnson, Lauren K., Munoz-Price, Silvia, Patel, Poonam Beniwal, Patel, Amir, Stein, Daniel J., Yarur, Andres J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922265/ https://www.ncbi.nlm.nih.gov/pubmed/35479586 http://dx.doi.org/10.20524/aog.2022.0690 |
Ejemplares similares
-
Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
por: Sekhri, Shaina, et al.
Publicado: (2021) -
The interplay of Clostridioides difficile
infection and inflammatory bowel disease
por: Sehgal, Kanika, et al.
Publicado: (2021) -
A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy
por: Patel, Sanket, et al.
Publicado: (2023) -
Management of Clostridioides difficile infection in patients with inflammatory bowel disease
por: Khanna, Sahil
Publicado: (2021) -
An Atypical Case of Monomicrobial Clostridioides difficile Septicemia With No Gastrointestinal Manifestations
por: Wang, Liqian, et al.
Publicado: (2022)